Atypical Rho-guanine nucleotide exchange factors (Rho-GEFs) that contain Dock homology regions (DHR-1 and DHR-2) are expressed in a variety of tissues; however, their functions and mechanisms of action remain unclear. We identify key conserved amino acids in the DHR-2 domain that are critical for the catalytic activity of Dock-GEFs (Dock1-4). We further demonstrate that Dock-GEFs directly associate with WASP family verprolin-homologous (WAVE) proteins through the DHR-1 domain. Brain-derived neurotrophic factor (BDNF)-TrkB signaling recruits the Dock3/WAVE1 complex to the plasma membrane, whereupon Dock3 activates Rac and dissociates from the WAVE complex in a phosphorylation-dependent manner. BDNF induces axonal sprouting through Dock-dependent Rac activation, and adult transgenic mice overexpressing Dock3 exhibit enhanced optic nerve regeneration after injury without affecting WAVE expression levels. Our results highlight a unique mechanism through which Dock-GEFs achieve spatial and temporal restriction of WAVE signaling, and identify Dock-GEF activity as a potential therapeutic target for axonal regeneration.
tional interactions (11, 12) . Recent studies have demonstrated that neurotrophins play important roles during gastrulation, in the differentiation of hepatic stellate cells, and in neurulation, through the regulation of Rho-GTPases (9, 13, 14) . Considering their relatively ubiquitous expression patterns, it is conceivable that Dock family members, in combination with neurotrophins, could be involved in the development and function of a variety of organs (15) (16) (17) .
Here, we report that the atypical Rho-GEFs Dock1-4 share key amino acids within the DHR-2 domain that are critical for catalytic activity, and furthermore, that they bind directly to WAVE proteins through the DHR-1 domain. Moreover, we provide both in vitro and in vivo evidence that neuron-specific Dock3 plays a critical role in the membrane trafficking of WAVE proteins and also participates in axonal outgrowth in the adult CNS as an essential downstream component of BDNF-TrkB signaling.
Results

Identification of Critical Residues Involved in GEF Catalytic Activity.
To identify residues critical for Rac1 activation, we constructed several Dock3 DHR-2 domain deletion mutants (Fig. 1A) and measured their catalytic activity with a GST-CRIB assay (Fig. 1B) . All of the deletion mutants failed to activate Rac1 (Fig. 1B) , indicating that amino acids 1358-1375 are required for Dock3-mediated GEF activity. We next introduced single alanine mutations into each of the 18 DHR-2 domain amino acids within fulllength Dock3 and found that mutation at F1359, Y1360, G1361, Y1373, or V1374 completely abolished Rac1 activation (Fig. 1C ) without affecting its ability to interact with Rac1 (Fig. 1D ). Because the DHR-2 domain is highly conserved among Dock1-4 ( Fig. 1A) , the five single alanine substitutions corresponding to those found in Dock3 were introduced into Dock1, Dock2, and Dock4. All of the mutations drastically reduced Rac1 activation (Fig. S1 ), demonstrating that these five amino acids of the DHR-2 domain are critical for GEF catalytic activity in all Rac-specific Dock family members. Dock3 Regulates Axonal Outgrowth. To evaluate whether Dock3 induces axonal outgrowth, we transfected primary cultured hippocampal neurons with plasmid encoding Dock3. Overexpression of Dock3 significantly stimulated axonal outgrowth compared with the control (Fig. 2 A and B) . As neurotrophic factors such as BDNF may also regulate Rac1 activation (18), we next examined whether Dock3 and BDNF have a synergistic effect on axonal outgrowth. Overexpression of wild-type (WT) Dock3 increased BDNF-mediated Author contributions: K.N. and T.H. designed research; K.N., C.H., C.T., and X.G. performed research; K.N., C.T., H.K., and L.F.P. contributed new reagents/analytic tools; K.N., C.H., X.G., L.F.P., and T.H. analyzed data; and K.N., L.F.P., and T.H. wrote the paper.
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This article contains supporting information online at www.pnas.org/cgi/content/full/ 0914514107/DCSupplemental. axonal outgrowth (Fig. 2 A and B) , whereas Dock3 siRNA for downregulating endogenous Dock3 inhibited the effect of BDNF (Fig. 2B) . Combinatorial siRNA to Dock1-4 decreased the baseline axon length (Fig. 2B ). In addition, Dock3
Y1360A and Dock3
Y1373A
also inhibited the effect of BDNF (Fig. 2B ). BDNF-mediated axonal outgrowth and Rac1 activation were observed in cultured neurons from WT and p75 NTR KO mice, but not from TrkB KO mice (Fig.  S2) . Trk receptor-specific inhibitor K252a and overexpression of dominant-negative Rac1 (Rac1 N17) suppressed BDNF-mediated axonal outgrowth (Fig. S2) . Furthermore, we found that Dock3 is expressed in retinal ganglion cells (RGCs) and has a synergistic effect with BDNF on axonal outgrowth in cultured RGCs (Fig. S3) . In retinal explant cultures, Dock3 protein was concentrated in growth cones (arrows in Fig. 2C ) and was diffuse in cytoplasm (control panel in Fig. 2C ). However, BDNF treatment rearranged Dock3 staining to the cell periphery (arrowheads in Fig. 2 C and D) . These data demonstrate that Dock3 act in concert, upstream of Rac1, to promote axonal outgrowth through TrkB receptor signaling.
Interaction of Dock3 and Fyn at the Growth Cone. One consequence of the presence of BDNF in neurons is the activation of Fyn and its association with the TrkB receptor (19) . Indeed, BDNF induced Fyn activation via phosphorylation at Y416 in primary cultured hipocampal neurons (Fig. 3A) . Because the proline-rich motif of Dock3 binds to SH3 domain-containing proteins (8), we next examined whether Fyn, which also possesses an SH3 domain, interacts with Dock3. A GST-fusion protein of the proline-rich Dock3 C terminus (amino acids 1773-2028) coprecipitated Fyn in lysates of mouse brain as well as Fyn-transfected Cos-7 cells (Fig.  3B) . In addition, a His-tag pull-down assay in Cos-7 cells transfected with His-tagged Dock3 together with WT Fyn, constitutively active Fyn Y528F , or ΔSH3 Fyn Y528F (20) , confirmed the SH3 domain requirement and preferential binding to the active form of Fyn (Fig. 3C) . In contrast, Fyn failed to bind to Elmo (21) , which interacts with Dock1-4 and enhances their GEF activities (Fig. S4) . Thus, the BDNF/TrkB-dependent activation and association with Fyn is specific. Consistent with the activated TrkB association with Fyn and interaction with Dock3, Dock3 translocated from cytosol to the membrane in SY5Y cells transfected with TrkB and Fyn Y528F in the presence of BDNF, but not in cells transfected with TrkB and ΔSH3 Fyn Y528F (Fig. 3D ). In addition, BDNF-treated retinal explants exhibit colocalization of Dock3 and Fyn at the peripheral regions of the growth cone (arrowheads in Fig. 3E ). These results are consistent with a model whereby BDNF-TrkB signaling induces the formation of a protein complex of Dock3 at the plasma membrane ( Fig. 2 C and D) . We further constructed a mutant Dock3 lacking Fyn binding domain (Δ1773- 
2028) and found that this mutant failed to stimulate BDNFinduced axonal outgrowth (Fig. 3F).
Direct Interaction of Dock3 and WAVE Proteins. Because WAVE proteins play a major role in Rac-induced actin dynamics, including actin nucleation and polymerization (3, 4), we speculated that they could be involved in Dock3-mediated axonal outgrowth. To investigate the possibility that WAVE1 can directly bind to Dock3, we performed a His-tag pull-down assay using WT Dock3 or several Dock3 truncation mutants. We found that Dock3 directly bound to WAVE1 at the DHR-1 domain (Fig. 4A) . We next constructed a mutant that lacks the DHR-1 domain (ΔDHR-1) and determined that this mutant also failed to bind to WAVE1 (Fig. 4B) . We further confirmed that the DHR-1 domain of Dock3 was required to mediate WAVE1-3 binding (Fig. 4C) . Indeed, this interaction between Dock and WAVE proteins can be generalized (Fig. S5 ). In addition, we demonstrated that ΔDHR-1 failed to stimulate BDNF-induced axonal outgrowth in hippocampal neurons (Fig. 4D) . We next prepared both WT and two mutant forms of WAVE1 constructs and found that one mutant that lacks the WAVE-homology domain (WHD) failed to bind to WT Dock3 (Fig. 4E) . Based on the preceding data, we hypothesized that membrane targeting of Dock3 may regulate the intracellular localization of WAVE. To assess this possibility, we transfected SY5Y cells with WT Dock3 and subjected them to immunocytochemistry. Overexpression of WT Dock3 did not change the intracellular localization of WAVE1 (Fig. 4F) . In contrast, overexpression of farnesylated Dock3 (F-Dock3, a membrane-targeted form of Dock3) translocated WAVE1 from the cytoplasm to the peripheral regions (arrowheads in Fig. 4F ). Taken together, these results suggest that the DHR-1 domain of Dock family proteins mediates direct binding to WAVE proteins leading to colocalization at the cell periphery and axonal outgrowth.
We also found a strong enhancement of the Dock3 upper mobility band (arrow in Fig. 4G ) in Cos-7 cells transfected with FDock3 but not with WT Dock3 (26 ± 6% and 2 ± 1% of total Dock3, respectively). Consistent with the upper mobility band representing a phosphorylated form of Dock3, the mobility shift was eliminated by phosphatase treatment (Fig. 4G) . We next examined the effect of Dock3 phosphorylation on its ability to bind WAVE. Cos-7 cells were transfected with His-tagged WAVE1 and F-Dock3 and subjected to a pull-down assay. Immunoblot analysis revealed that WAVE1 binds to the unphosphorylated form of Dock3 more effectively than to the phosphorylated form (Fig. 4H) . Thus, the Dock3/WAVE1 complex may dissociate upon Dock3 phosphorylation, leading to spatially restricted actin dynamics through WAVE signaling.
Promoting Axonal Outgrowth in Adult CNS by Modulating Dock3 Activity.
To investigate the effects of Dock3 in vivo, we generated transgenic (Tg) mice overexpressing WT Dock3 under control of the actin promoter. Tg mice showed high expression levels of Dock3 in many tissues, especially in the optic nerve (∼5.6-fold) and retina (∼2.3-fold; Fig. S6A ), but the structure of such tissues were normal (Fig. S6  B and C) . Therefore, we prepared retinal explants from WT and Tg mice and examined the effect of Dock3 on axon length. Quantitative analysis revealed that axon length was clearly greater in Tg mice than in their WT littermates (Fig. 5A) . Furthermore, Dock3 and BDNF exerted synergistic effects on axonal growth, as observed in vitro ( Fig. 2 A and B) . These results suggest that axonal outgrowth is promoted in Dock3 Tg mice. To explore this possibility, we used the optic nerve microcrush model and investigated the extent of axonal outgrowth 2 weeks after injury by staining with GAP43 antibody (22) . WT mice subjected to nerve crush showed >40 axons extending 200 μm from the injury site, and half this number extended 500 μm. In contrast, Tg mice had, on average, >80 axons extending 200 μm and >60 axons extending 500 μm beyond the lesion site (Fig. 5B) . Immunohistochemical analysis of Dock3 and WAVE1 in injured optic nerves revealed that their coexpression was hardly detectable in WT mice, but was clearly increased in regenerating axons in Tg mice (Fig. 5C ). We next examined the levels of Dock3 and WAVE1 proteins in optic nerves by immunoblotting (Fig. S7) . Dock3 protein was reduced in injured WT optic nerves (decreased to ∼10% of control), but this reduction was less severe in Tg mice. In both WT and Tg mice, WAVE1 protein was less abundant after the injury (reduced to ∼60%). Whereas in the membrane fraction of crushed optic nerves, Dock3 and WAVE1 expression levels in Tg mice were significantly higher than WT mice ( Fig. 5D and E) . We also examined the expression of TrkB and Fyn in injured optic nerves, but their expression levels in Tg mice were not significantly altered compared with those in WT mice (Fig. S8) . Thus, overexpression of Dock3 does not affect the expression levels of its binding partners, but may induce axonal outgrowth through effective membrane recruitment of WAVE1.
Discussion
In the present study, we found that Dock1-4, which are atypical members of the Rho-GEF family, share several conserved amino acids in their DHR-2 domains that are required for GEF activity. In addition, Dock1-4 bind directly to WAVE1-3 via their DHR-1 domains, and this is disrupted when Dock1-4 become phosphorylated. We further showed that Dock3 forms a protein complex with Fyn and WAVE1 at the plasma membrane downstream of TrkB. Finally, we demonstrated that overexpression of Dock3 increases WAVE1 expression levels in the plasma membrane and promotes optic nerve regeneration in vivo. Taken together, our results suggest a unique mechanism for axonal outgrowth through which Dock-GEFs recruit WAVE proteins to specific sites within cells and induce spatially restricted actin dynamics in the CNS (Fig. 6) .
BDNF/TrkB signaling is important for a variety of CNS developmental processes including synaptic pruning (23, 24) . In addition, Rho-GTPase signaling can affect both spine structure and synaptic function (25, 26) . In this study, we found that treatment of hippocampal neurons with BDNF enhances Rac1 activation and neurite outgrowth. It is therefore possible that Dock-GEFs mediate multiple BDNF/TrkB functions, including the establishment of longterm potentiation. On the other hand, loss of Dock3 leads to sensorimotor impairments and structural changes, including axonal swellings, but had no effects on life span or fertility (15) . These relatively mild phenotypes are reasonable, considering the redundant catalytic sequences found in the DHR-2 domains of Dock1-4. Recent studies have revealed that a Val66Met polymorphism in human BDNF is involved in the pathogenesis of attention-deficit/ hyperactivity disorder (ADHD) (27) (28) (29) . Interestingly, a pericentric inversion breakpoint in the DOCK3 gene has been described in ADHD patients (30) . Thus, further study is required to determine the full implications of the Dock-GEFs in BDNF-associated development, adult physiology, and disease. Dock3 overexpression induced optic nerve regeneration after injury without affecting expression levels of its binding partners. For example, WAVE1 expression level after optic nerve injury was decreased to ∼60% in both WT and Dock3 Tg mice. However, WAVE1 expression was increased in the membrane fraction and was coexpressed with Dock3 in the regenerating axons. Thus, the tight regulation of Rac1-GDP/Rac1-GTP cycling and effective membrane recruitment of WAVE proteins by Dock3, rather than prolonged activation of Rac1 or WAVE proteins (31) (32) (33) , may be required for axonal growth via actin polymerization. Our present findings support the notion that neurons have to intrinsically upregulate the necessary growth-associated molecules to extend an axon (34, 35) . On the other hand, recent studies have shown that glial scarring and several myelin inhibitors block axonal growth following CNS injury (35, 36) . Thus, overexpression of Dock-GEFs may have a synergistic effect in combination with suppression of glial scarring and myelin-associated inhibitory signaling.
Lack of axonal regeneration in the adult CNS is one of the most important issues to be resolved in various neurodegenerative disorders. For example, glaucoma is characterized by a slow progressive degeneration of optic nerve axons. Thus, Dock/WAVE complexes and their related binding partners may be possible therapeutic targets in multiple forms of glaucoma that otherwise lead to severe visual impairment. We are presently investigating these issues by crossing Dock3 Tg mice with glutamate transporter knockout mice, which are the first animal models of normal tension glaucoma (37) . Thus, further studies are required to explore the full potential of Dock-GEFs that could be used for effective regeneration therapy.
Materials and Methods
Experimental Animals. Experiments were performed using p75 NTR knockout and TrkB × hGFAP-cre knockout (TrkB KO) mice in accordance with the Tokyo Metropolitan Institute for Neuroscience Guidelines for the Care and Use of Animals. The TrkB deletion was confirmed in the hippocampus of the TrkB KO mice (23) . A Tg construct containing the CAG promoter, Dock3 coding sequence (GenBank accession no. NM_153413), and a polyadenylation signal was used to generate Dock3 Tg mice. The founder mice were generated by injecting the transgene into fertilized C57BL/6 eggs. RGCs were retrogradely labeled with Fluoro-Gold (Fluorochrome) as previously described (38) .
Cell Culture. Primary cultured hippocampal neurons (39) and retinal explants (22) were prepared from E16 mice. In some experiments, they were stimulated with BDNF (5 or 50 ng/mL; Alomone Labs).
Plasmids and siRNA Transfection. WAVE1-3 plasmids were provided by T. Takenawa (40) . Elmo2 and GST-CRIB plasmids were provided by H. Kato and M. Negishi (21) . Rac and Dock1 plasmids were provided by M. Matsuda (41) . Dock3, Fyn, and WAVE1 fragments were PCR-amplified from full-length cDNAs and expressed as His-tagged proteins. Alanine substitutions were generated with the PrimeSTAR Mutagenesis Basal Kit (Takara). RNA oligomers containing 21 nucleotides for RNA interference for Dock1-4 were synthesized in the sense and antisense directions (Dock1: 5′-GGAAGUCACCACAACGCU UUU-3′; Dock2: 5′-GCAUCUCA CGCUACAGAUUUU-3′; Dock3: 5′-GCAGAUCA GUGAACGGUUUU-3′; Dock4: 5′-GCAAGAGUGUGGCCAGAAAUU-3′) (JBioS). Transfection of siRNAs and plasmids was performed using the Nucleofector System (Amaxa) or Lipofectamine Plus (Invitrogen).
Pull-Down Assay. His-tagged proteins were purified from Cos-7 cell lysates with TALON resin (BD Biosciences) for 20 min at 4°C with gentle agitation. The protein levels of Rac-GTP were measured by affinity precipitation using the GST-CRIB of PAK1. Bacterial GST-fusion proteins were incubated with lysates from Cos-7 cells or mouse brains. The precipitated samples were subjected to SDS-PAGE followed by immunoblot analysis (8) with the following antibodies: Fyn, phospho-Fyn (Tyr416) and WAVE1 were obtained from BD Biosciences; WAVE2 and WAVE3 were obtained from Santa Cruz.
Immunostaining. SY5Y cells, retinal explants, sections of retina, and optic nerves were incubated with anti-Dock3 (1:200), anti-WAVE1 (1:200), and anti-GAP43 (1:1,000; Chemicon) antibodies. Cy2-conjugated donkey antirabbit IgG or Cy3-conjugated donkey antimouse IgG were used as secondary antibodies. F-actin was visualized with rhodamine-labeled phalloidin (Invitrogen).
Optic Nerve Injury. Mice were anesthetized with sodium pentobarbital before optic nerve crush. Optic nerves were exposed intraorbitally and crushed about 0.5-1.0 mm from the posterior pole of the eyeball with fine surgical forceps for 5 s (22) . Fourteen days after surgery, axonal outgrowth was quantified by counting GAP43-positive axons that crossed a virtual line parallel to the lesion site at 200 μm and 500 μm distal to the lesion site. Protein expression levels in the lesion site were measured by immunoblot analysis with antibodies against Dock3 and WAVE1-3. Membrane fraction was prepared as previously described (42) .
Image Analysis and Statistics. To measure axon length, the longest axon of each neuron was traced and calculated using National Institutes of Health ImageJ (version 1.38) . Approximately 50 neurons with axons were scanned using a DP70 CCD camera (Olympus). Data are presented as mean ± SEM. For statistical analyses, a two-tailed Student's t test was used. Values of P < 0.05 were regarded as statistically significant.
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